OFI Invest Asset Management boosted its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 4.9% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 71,375 shares of the healthcare conglomerate's stock after purchasing an additional 3,335 shares during the period. OFI Invest Asset Management's holdings in UnitedHealth Group were worth $22,267,000 at the end of the most recent quarter.
A number of other large investors have also added to or reduced their stakes in the stock. Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. grew its position in UnitedHealth Group by 4.8% in the 2nd quarter. Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. now owns 8,168 shares of the healthcare conglomerate's stock worth $2,548,000 after purchasing an additional 375 shares during the period. Vanguard Personalized Indexing Management LLC boosted its stake in shares of UnitedHealth Group by 1.7% during the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 100,498 shares of the healthcare conglomerate's stock worth $31,376,000 after acquiring an additional 1,645 shares during the last quarter. Lincluden Management Ltd. boosted its stake in shares of UnitedHealth Group by 73.1% during the 2nd quarter. Lincluden Management Ltd. now owns 14,408 shares of the healthcare conglomerate's stock worth $4,495,000 after acquiring an additional 6,084 shares during the last quarter. Sather Financial Group Inc boosted its stake in shares of UnitedHealth Group by 1,252.5% during the 2nd quarter. Sather Financial Group Inc now owns 20,585 shares of the healthcare conglomerate's stock worth $6,422,000 after acquiring an additional 19,063 shares during the last quarter. Finally, Udine Wealth Management Inc. purchased a new position in shares of UnitedHealth Group during the 2nd quarter worth $2,349,000. Institutional investors own 87.86% of the company's stock.
Analyst Ratings Changes
UNH has been the topic of several analyst reports. KeyCorp lifted their price target on shares of UnitedHealth Group from $350.00 to $400.00 and gave the stock an "overweight" rating in a research note on Wednesday. Mizuho lifted their target price on shares of UnitedHealth Group from $300.00 to $430.00 and gave the company an "outperform" rating in a research note on Thursday. Cantor Fitzgerald restated an "overweight" rating and set a $440.00 target price on shares of UnitedHealth Group in a research note on Tuesday, August 26th. JPMorgan Chase & Co. lifted their target price on shares of UnitedHealth Group from $310.00 to $425.00 and gave the company an "overweight" rating in a research note on Thursday. Finally, Baird R W cut shares of UnitedHealth Group from a "hold" rating to a "strong sell" rating in a research note on Thursday, July 31st. Sixteen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus target price of $383.09.
Read Our Latest Stock Analysis on UnitedHealth Group
UnitedHealth Group Stock Down 3.6%
Shares of UNH stock opened at $354.30 on Friday. The company's fifty day simple moving average is $318.21 and its two-hundred day simple moving average is $349.25. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The stock has a market cap of $320.88 billion, a P/E ratio of 15.35, a PEG ratio of 2.29 and a beta of 0.47.
UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. During the same quarter last year, the firm earned $6.80 earnings per share. The business's quarterly revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
UnitedHealth Group Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were issued a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.5%. The ex-dividend date was Monday, September 15th. UnitedHealth Group's dividend payout ratio is presently 38.30%.
About UnitedHealth Group
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.